New Release of Advarra's Study Collaboration Solution Provides Sponsors and CROs a Single View into the Progress of Site ...

There is a risk of delays in site activation and patient enrollment, which could impact the study timeline. The company faces commercial risks despite the potential advantages of Niyad over ...

Q4 2024 Earnings Call Transcript March 31, 2025 Talphera, Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.21. Operator: Welcome to the Talphera Fourth Quarter and Full ...